Ovid Therapeutics Inc. Annual Operating Income (Loss) in USD from 2015 to 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Ovid Therapeutics Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2015 to 2024.
  • Ovid Therapeutics Inc. Operating Income (Loss) for the quarter ending December 31, 2024 was -$10.7M, a 41% increase year-over-year.
  • Ovid Therapeutics Inc. Operating Income (Loss) for the twelve months ending December 31, 2024 was -$61.9M, a 4.39% decline year-over-year.
  • Ovid Therapeutics Inc. annual Operating Income (Loss) for 2024 was -$61.9M, a 4.39% decline from 2023.
  • Ovid Therapeutics Inc. annual Operating Income (Loss) for 2023 was -$59.3M, a 6.72% decline from 2022.
  • Ovid Therapeutics Inc. annual Operating Income (Loss) for 2022 was -$55.5M, a 145% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$61.9M -$2.6M -4.39% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-11
2023 -$59.3M -$3.73M -6.72% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-11
2022 -$55.5M -$180M -145% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-08
2021 $124M +$206M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-13
2020 -$81.4M -$20M -32.6% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-15
2019 -$61.4M -$8.48M -16% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-15
2018 -$52.9M +$12.1M +18.6% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-11
2017 -$65M -$42.5M -188% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-07
2016 -$22.5M -$9.34M -70.8% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-29
2015 -$13.2M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.